Retour
54
Fourchette du Jour
58,43 €
59,99 €
Fourchette 52 Semaines
47,32 €
87,32 €
Volume
307 419
Moyenne 50J / 200J
65,06 €
/
65,66 €
Clôture Précédente
58,58 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 16,3 | 0,4 |
| P/B | 3,3 | 2,9 |
| ROE % | 18,8 | 3,8 |
| Net Margin % | 12,3 | 3,9 |
| Rev Growth 5Y % | 11,8 | 10,0 |
| D/E | 1,5 | 0,2 |
Objectif de Cours des Analystes
Hold
86,60 €
+48.1%
Low: 80,00 €
High: 94,00 €
P/E Prévisionnel
11,8
BPA Prévisionnel
4,95 €
Croissance BPA (est.)
+0,0%
CA Est.
1,3 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
7,66 €
7,54 € – 7,76 €
|
1,8 B | 3 |
| FY2029 |
6,90 €
6,79 € – 6,99 €
|
1,6 B | 3 |
| FY2028 |
5,93 €
5,52 € – 6,17 €
|
1,5 B | 5 |
Points Clés
Revenue grew 11,82% annually over 5 years — strong growth
Earnings grew 42,64% over the past year
ROE of 18,83% — decent returns on equity
Generating 142,45M in free cash flow
PEG of 0,44 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,87%
Croissance
Revenue Growth (5Y)
11,82%
Revenue (1Y)3,95%
Earnings (1Y)42,64%
FCF Growth (3Y)-6,48%
Qualité
Return on Equity
18,83%
ROIC8,13%
Net Margin12,32%
Op. Margin16,30%
Sécurité
Debt / Equity
1,49
Current Ratio1,62
Interest Coverage22,76
Valorisation
P/E Ratio
16,32
P/B Ratio3,33
EV/EBITDA16,48
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,95% | Revenue Growth (3Y) | 7,91% |
| Earnings Growth (1Y) | 42,64% | Earnings Growth (3Y) | 20,54% |
| Revenue Growth (5Y) | 11,82% | Earnings Growth (5Y) | 20,52% |
| Profitability | |||
| Revenue (TTM) | 1,36B | Net Income (TTM) | 167,68M |
| ROE | 18,83% | ROA | 6,84% |
| Gross Margin | 57,21% | Operating Margin | 16,30% |
| Net Margin | 12,32% | Free Cash Flow (TTM) | 142,45M |
| ROIC | 8,13% | FCF Growth (3Y) | -6,48% |
| Safety | |||
| Debt / Equity | 1,49 | Current Ratio | 1,62 |
| Interest Coverage | 22,76 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 16,32 | P/B Ratio | 3,33 |
| P/S Ratio | 2,01 | PEG Ratio | 0,44 |
| EV/EBITDA | 16,48 | Dividend Yield | 0,00% |
| Market Cap | 2,74B | Enterprise Value | 3,65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,36B | 1,31B | 1,17B | 993,20M | 870,46M |
| Net Income | 167,68M | 117,56M | 115,40M | 43,38M | 79,47M |
| EPS (Diluted) | 3,31 | 2,29 | 2,24 | 0,84 | 1,55 |
| Gross Profit | 778,55M | 711,92M | 622,87M | 530,77M | 428,45M |
| Operating Income | 221,82M | 164,88M | 156,03M | 80,75M | 89,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,45B | 2,20B | 1,93B | 1,86B | 1,82B |
| Total Liabilities | 1,63B | 1,24B | 1,12B | 1,11B | 1,09B |
| Shareholders' Equity | 820,84M | 959,96M | 818,00M | 749,42M | 731,67M |
| Total Debt | 1,22B | 807,79M | 765,89M | 780,79M | 778,28M |
| Cash & Equivalents | 306,76M | 178,80M | 284,47M | 259,50M | 192,31M |
| Current Assets | 934,98M | 768,90M | 769,72M | 756,03M | 693,55M |
| Current Liabilities | 578,11M | 300,38M | 251,82M | 442,27M | 253,50M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#145 of 326
Activité Récente
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026